MELANIE LYON: Open Payments
NPI 1699436592 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 23 payments from 11 companies in 2025. Trend: 2023 $695 · 2024 $1,026 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $151 |
| Amgen Inc. | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Novo Nordisk Inc | 2 | $45 |
| Daiichi Sankyo Inc. | 2 | $43 |
| SCPHARMACEUTICALS INC. | 2 | $38 |
| Fresenius USA Marketing, Inc. | 2 | $36 |
| GENZYME CORPORATION | 1 | $28 |
| Calliditas Therapeutics US Inc. | 1 | $23 |
Products named: Vanrafia, JYNARQUE, KRYSTEXXA, JARDIANCE, Ozempic, INJECTAFER, FUROSCIX, VELPHORO.
Industry payments across MI — which companies pay providers there.
